Doctors often prescribe GLP-1 agonists to people whove been diagnosed with type 2 diabetes, obesity, or both
Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, Dixon RJ, Meitinger T, Braund P, Wichmann HE, Barrett JH, Knig IR, Stevens SE, Szymczak S, Tregouet DA, Iles MM, Pahlke F, Pollard H, Lieb W, Cambien F, Fischer M, Ouwehand W, Blankenberg S, Balmforth AJ, Baessler A, Ball SG, Strom TM, Braenne I, Gieger C, Deloukas P, Tobin MD, Ziegler A, Thompson JR, Schunkert H, WTCCC and the Cardiogenics Consortium
Zepbound (Tirzepatide) Zepbound combines the power of GLP-1 and GIP hormones, yielding enhanced weight loss effects
The tirzepatideGIPRG s complexes were collected and concentrated for cryo-EM analysis